Published in Ann Neurol on November 01, 2012
Adaptive deep brain stimulation in advanced Parkinson disease. Ann Neurol (2013) 3.05
The nature of tremor circuits in parkinsonian and essential tremor. Brain (2014) 1.51
Closing the loop of deep brain stimulation. Front Syst Neurosci (2013) 1.07
Coordinated reset neuromodulation for Parkinson's disease: proof-of-concept study. Mov Disord (2014) 1.00
Reversing pathologically increased EEG power by acoustic coordinated reset neuromodulation. Hum Brain Mapp (2013) 0.98
Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality? Neurotherapeutics (2016) 0.96
Phase dependent modulation of tremor amplitude in essential tremor through thalamic stimulation. Brain (2013) 0.95
Mechanisms of deep brain stimulation. J Neurophysiol (2015) 0.93
Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state. Front Neuroanat (2015) 0.93
Focusing brain therapeutic interventions in space and time for Parkinson's disease. Curr Biol (2014) 0.93
Engineering the next generation of clinical deep brain stimulation technology. Brain Stimul (2014) 0.92
Maladaptive neural synchrony in tinnitus: origin and restoration. Front Neurol (2015) 0.88
Evaluation of the acoustic coordinated reset (CR®) neuromodulation therapy for tinnitus: study protocol for a double-blind randomized placebo-controlled trial. Trials (2013) 0.86
Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the Pipeline. Int J Neurosci (2015) 0.82
Stimulating at the right time: phase-specific deep brain stimulation. Brain (2016) 0.81
Locally optimal extracellular stimulation for chaotic desynchronization of neural populations. J Comput Neurosci (2014) 0.81
Augmented brain function by coordinated reset stimulation with slowly varying sequences. Front Syst Neurosci (2015) 0.80
Desynchronization boost by non-uniform coordinated reset stimulation in ensembles of pulse-coupled neurons. Front Comput Neurosci (2013) 0.80
Neuronal circuits and physiological roles of the basal ganglia in terms of transmitters, receptors and related disorders. J Physiol Sci (2016) 0.79
Putting reins on the brain. How the body and environment use it. Front Hum Neurosci (2014) 0.79
Self-organized noise resistance of oscillatory neural networks with spike timing-dependent plasticity. Sci Rep (2013) 0.79
The spacing principle for unlearning abnormal neuronal synchrony. PLoS One (2015) 0.79
Neuromodulation: selected approaches and challenges. J Neurochem (2012) 0.79
Phasic Burst Stimulation: A Closed-Loop Approach to Tuning Deep Brain Stimulation Parameters for Parkinson's Disease. PLoS Comput Biol (2016) 0.78
Clustered Desynchronization from High-Frequency Deep Brain Stimulation. PLoS Comput Biol (2015) 0.78
Coordinated reset stimulation in a large-scale model of the STN-GPe circuit. Front Comput Neurosci (2014) 0.78
Control of abnormal synchronization in neurological disorders. Front Neurol (2014) 0.77
Task specific inter-hemispheric coupling in human subthalamic nuclei. Front Hum Neurosci (2014) 0.77
A Novel Lead Design for Modulation and Sensing of Deep Brain Structures. IEEE Trans Biomed Eng (2015) 0.77
Randomized, Blinded Pilot Testing of Nonconventional Stimulation Patterns and Shapes in Parkinson's Disease and Essential Tremor: Evidence for Further Evaluating Narrow and Biphasic Pulses. Neuromodulation (2016) 0.77
Optimal number of stimulation contacts for coordinated reset neuromodulation. Front Neuroeng (2013) 0.76
Closed-loop stimulation of a delayed neural fields model of parkinsonian STN-GPe network: a theoretical and computational study. Front Neurosci (2015) 0.76
Anti-kindling Induced by Two-Stage Coordinated Reset Stimulation with Weak Onset Intensity. Front Comput Neurosci (2016) 0.76
Acoustic Coordinated Reset Neuromodulation: A Systematic Review of a Novel Therapy for Tinnitus. Front Neurol (2017) 0.75
The role of environmental constraints in walking: Effects of steering and sharp turns on gait dynamics. Sci Rep (2016) 0.75
Modulation of Neuronal Activity in the Motor Thalamus during GPi-DBS in the MPTP Nonhuman Primate Model of Parkinson's Disease. Brain Stimul (2016) 0.75
Adaptive Deep Brain Stimulation for Movement Disorders: The Long Road to Clinical Therapy. Mov Disord (2017) 0.75
Asynchronous Distributed Multielectrode Microstimulation Reduces Seizures in the Dorsal Tetanus Toxin Model of Temporal Lobe Epilepsy. Brain Stimul (2015) 0.75
Dendritic and Axonal Propagation Delays Determine Emergent Structures of Neuronal Networks with Plastic Synapses. Sci Rep (2017) 0.75
Capacitive Feedthroughs for Medical Implants. Front Neurosci (2016) 0.75
Cell-specific pallidal intervention induces long-lasting motor recovery in dopamine-depleted mice. Nat Neurosci (2017) 0.75
Pulsatile desynchronizing delayed feedback for closed-loop deep brain stimulation. PLoS One (2017) 0.75
Network effects of deep brain stimulation. J Neurophysiol (2015) 0.75
Advances in closed-loop deep brain stimulation devices. J Neuroeng Rehabil (2017) 0.75
Subthalamic Nucleus Deep Brain Stimulation: Basic Concepts and Novel Perspectives. eNeuro (2017) 0.75
Vibrotactile Coordinated Reset Stimulation for the Treatment of Neurological Diseases: Concepts and Device Specifications. Cureus (2017) 0.75
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06
The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol (2013) 2.65
Evaluating a surrogate endpoint at three levels, with application to vaccine development. Stat Med (2008) 2.50
A wireless passive pressure microsensor fabricated in HTCC MEMS technology for harsh environments. Sensors (Basel) (2013) 2.44
Evidence of dysregulation of dendritic cells in primary HIV infection. Blood (2010) 2.39
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol (2014) 2.33
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol (2009) 2.28
Competition between feedback loops underlies normal and pathological dynamics in the basal ganglia. J Neurosci (2006) 2.26
Novel pharmacological targets for the treatment of Parkinson's disease. Nat Rev Drug Discov (2006) 2.23
Counteracting tinnitus by acoustic coordinated reset neuromodulation. Restor Neurol Neurosci (2012) 2.20
Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain (2005) 2.19
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc Natl Acad Sci U S A (2012) 2.16
Preparatory activity in motor cortex reflects learning of local visuomotor skills. Nat Neurosci (2003) 2.05
Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J Virol (2010) 2.02
Association of functional variations in COMT and GCH1 genes with postherniotomy pain and related impairment. Pain (2015) 2.01
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol (2010) 1.80
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat Med (2003) 1.73
Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model. Exp Neurol (2009) 1.70
Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design. J Virol (2008) 1.69
A predictive model for the detection of tumor lysis syndrome during AML induction therapy. Leuk Lymphoma (2006) 1.67
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. J Infect Dis (2011) 1.67
Priorities in Parkinson's disease research. Nat Rev Drug Discov (2011) 1.66
Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol (2005) 1.65
Informal caregiver burden among survivors of prolonged mechanical ventilation. Am J Respir Crit Care Med (2006) 1.64
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol (2009) 1.61
A multinational study of thromboprophylaxis practice in critically ill children. Crit Care Med (2014) 1.56
The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res (2010) 1.56
Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. J Neurosci (2002) 1.56
Arkypallidal Cells Send a Stop Signal to Striatum. Neuron (2016) 1.55
Mitochondrial localization of telomeric protein TIN2 links telomere regulation to metabolic control. Mol Cell (2012) 1.55
Delayed build-up of Arctic ice sheets during 400,000-year minima in insolation variability. Nature (2012) 1.53
Spike synchronization in the cortex/basal-ganglia networks of Parkinsonian primates reflects global dynamics of the local field potentials. J Neurosci (2004) 1.53
Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model. Mov Disord (2012) 1.51
Neuronal oscillations in the basal ganglia and movement disorders: evidence from whole animal and human recordings. J Neurosci (2004) 1.50
Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer Res (2011) 1.49
Factor VIII May Predict Catheter-Related Thrombosis in Critically Ill Children: A Preliminary Study. Pediatr Crit Care Med (2015) 1.44
L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor. J Neurosci (2012) 1.43
The causal relationship between subcortical local field potential oscillations and Parkinsonian resting tremor. J Neural Eng (2010) 1.41
A threshold method for immunological correlates of protection. BMC Med Res Methodol (2013) 1.41
FXTAS: new insights and the need for revised diagnostic criteria. Neurology (2012) 1.39
Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet (2010) 1.38
Weight gain prevention among women. Obesity (Silver Spring) (2007) 1.36
Genome-wide association study of homocysteine levels in Filipinos provides evidence for CPS1 in women and a stronger MTHFR effect in young adults. Hum Mol Genet (2010) 1.35
RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease. J Neurosci (2007) 1.35
Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci (2004) 1.30
Lysosomal impairment in Parkinson's disease. Mov Disord (2013) 1.27
Late emergence of synchronized oscillatory activity in the pallidum during progressive Parkinsonism. Eur J Neurosci (2007) 1.27
Association of FTO with obesity-related traits in the Cebu Longitudinal Health and Nutrition Survey (CLHNS) Cohort. Diabetes (2008) 1.26
Shaping of motor responses by incentive values through the basal ganglia. J Neurosci (2007) 1.24
Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease. Sci Transl Med (2010) 1.23
Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease? Prog Neurobiol (2008) 1.19
Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Brain (2008) 1.19
From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control. Prog Neurobiol (2002) 1.17
Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection. PLoS Pathog (2010) 1.16
Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors. J Neurosci (2003) 1.16
Dynamic changes in the cortex-basal ganglia network after dopamine depletion in the rat. J Neurophysiol (2008) 1.15
The nigrostriatal pathway in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol (2009) 1.13
Effective desynchronization by nonlinear delayed feedback. Phys Rev Lett (2005) 1.13
Microarray analysis of nonhuman primates: validation of experimental models in neurological disorders. FASEB J (2003) 1.13
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. Parkinsonism Relat Disord (2005) 1.13
Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial. PLoS One (2011) 1.13
The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol (2007) 1.12
Emerging patterns of neuronal responses in supplementary and primary motor areas during sensorimotor adaptation. J Neurosci (2005) 1.11
L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain. Neurobiol Dis (2005) 1.10
Control of neuronal synchrony by nonlinear delayed feedback. Biol Cybern (2006) 1.09
Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia. J Neurosci (2009) 1.09
Synergy of human immunodeficiency virus protease inhibitors with chloroquine against Plasmodium falciparum in vitro and Plasmodium chabaudi in vivo. Antimicrob Agents Chemother (2008) 1.09
Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia. PLoS One (2010) 1.08
Comparison of ENCODE region SNPs between Cebu Filipino and Asian HapMap samples. J Hum Genet (2007) 1.08
Landfill site selection using spatial information technologies and AHP: a case study in Beijing, China. J Environ Manage (2009) 1.08
Psychometric evaluation of visual analog scale for the assessment of chronic tinnitus. Am J Audiol (2012) 1.08
Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biol Psychiatry (2008) 1.07
Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia. J Neurosci (2006) 1.07
Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate. PLoS One (2010) 1.07
Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. Neurobiol Dis (2007) 1.06
Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells. Hum Gene Ther (2011) 1.05
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia. Proc Natl Acad Sci U S A (2010) 1.05
A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys. Neurobiol Dis (2010) 1.04
Brain hemispheres selectively track the expected value of contralateral options. J Neurosci (2009) 1.04
Unintended pregnancy influences racial disparity in tubal sterilization rates. J Gen Intern Med (2009) 1.04
Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic Biol Med (2005) 1.04
Normal cerebrovascular reactivity in Stroke-like Migraine Attacks after Radiation Therapy syndrome. Clin Nucl Med (2010) 1.02
Multiple system atrophy: current and future approaches to management. Ther Adv Neurol Disord (2010) 1.02
Vertically aligned boron nitride nanosheets: chemical vapor synthesis, ultraviolet light emission, and superhydrophobicity. ACS Nano (2010) 1.02
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease. J Neurosci (2008) 1.02
Competitive displacement between two invasive whiteflies: insecticide application and host plant effects. Bull Entomol Res (2013) 1.01
Linking the Tinnitus Questionnaire and the subjective Clinical Global Impression: which differences are clinically important? Health Qual Life Outcomes (2012) 1.01
Weight concerns affect motivation to remain abstinent from smoking postpartum. Ann Behav Med (2006) 1.01
Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway. Biol Psychiatry (2007) 1.01